Chemotherapy for prevention and treatment of prostate, colon, and other cancers. It has completed Phase IIa human clinical trialsite-from Myriad Genetics, Inc.
Genentech's mission is to develop drugs to address significant unmet medical needs. Genentech manufactures and markets seven products that help save or improve lives every day.
Develops and markets new compounds including antibiotics. Features investor information and product details. Waltham, Massachusetts, USA.
Pharmaceutical company developing novel antimalarial drugs candidates against resistant strains of Plasmodium falciparum.
Biopharmaceutical company focused on saving lives utilizing Samaritan Laboratories, Georgetown University's School of Medicine, to identify and design drugs for Alzheimer's, AIDS, cancer and cholesterol and process resulting "drug candidates" through the FDA to obtain approval.
Development of drugs for treatment of neurovascular, respiratory and allergic disorders, with career and subsidiary information, plus international contact details.
Develops and commercializes novel drugs for the treatment of neurological diseases and cancer. Information for patients and investors, with profile of company in Baltimore, Maryland. (Nasdaq: GLFD).
Develops small-molecule drugs for treatment of immunological, viral, and cardiovascular diseases and disorders, using structure-based drug design. Includes programs, trials and investors' profile, with headquarters in Birmingham, Alabama. (Nasdaq: BCRX)
Supplies components for genomic studies, and provides research, development and production services for clinical manufacturing. Includes details of products and technical resources. Headquarters in Liege, Belgium.
Development and marketing of medications used in the fields of neurology, dermatology and infectious diseases. Includes corporate and production details. Costa Mesa, California, USA.
|